J C Aldigier
Overview
Explore the profile of J C Aldigier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambaraud T, Dickson Z, Ensergueix G, Barraud O, Essig M, Lacour C, et al.
Transpl Infect Dis
. 2012 Sep;
14(6):E134-6.
PMID: 22998023
Bordetella holmesii is a gram-negative rod that was initially identified in 1995. It causes bacteremia, pneumonia, and endocarditis mostly in patients with anatomical or functional asplenia. We report here, to...
2.
Locatelli F, Mann J, Aldigier J, Sanz Guajardo D, Schmidt R, Van Vlem B, et al.
Clin Nephrol
. 2010 Feb;
73(2):94-103.
PMID: 20129016
Background: C.E.R.A., a continuous erythropoietin receptor activator, is a long-acting erythropoiesis-stimulating agent (ESA) that is approved for the treatment of renal anemia. This analysis evaluated the safety profile of C.E.R.A....
3.
Aldigier J, Meur Y, Brunel P
Clin Drug Investig
. 2008 Mar;
16(6):463-72.
PMID: 18370561
Research into progressive renal scarring has been closely linked over the last two decades with angiotensin II (AII). This has led to a better understanding of the mechanisms underlying the...
4.
Drouet M, Aupetit C, Denizot Y, Bois M, Bridoux F, Aldigier J, et al.
Clin Nephrol
. 2002 May;
57(4):253-60.
PMID: 12005241
Background: IgA nephropathy (IgA-N) is the most common glomerular disease. Various genetic factors have been suspected to influence the disease, but they never have been studied in the same cohort...
5.
Achard J, Leborgne L, Tribouilloy C, Aldigier J, Fournier A
Lancet
. 2001 Sep;
358(9283):757-8; author reply 758-9.
PMID: 11556340
No abstract available.
6.
Le Meur Y, Lorgeot V, COMTE L, Szelag J, Aldigier J, Praloran V
Am J Kidney Dis
. 2001 Sep;
38(3):510-7.
PMID: 11532682
N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a physiological inhibitor of hematopoiesis that is maintained at stable levels in normal plasma. Its degradation in vivo and in vitro by angiotensin-converting enzyme (ACE) accounts for...
7.
Denizot Y, Pinaud E, Aupetit C, Le Morvan C, Magnoux E, Aldigier J, et al.
Immunology
. 2001 May;
103(1):35-40.
PMID: 11380690
We studied the hs1,2 transcriptional enhancer identified downstream of the human alpha1 gene of the immunoglobulin H (IgH) locus, for which two different allelic configurations (a and b) were previously...
8.
Achard J, Oudart N, Aldigier J
Lancet
. 2000 Dec;
356(9245):1926-7; author reply 1928-9.
PMID: 11130401
No abstract available.
9.
Denizot Y, Aupetit C, Bridoux F, Alphonse J, Cogne M, Aldigier J
Nephrol Dial Transplant
. 2000 Sep;
15(9):1344-7.
PMID: 10978389
Background: Platelet-activating factor (PAF) is a phospholipid mediator with potent inflammatory activities. PAF stimulates IgA synthesis by B cells while IgA aggregates enhance PAF production by neutrophils and mesangial cells....
10.
Aupetit C, Drouet M, Pinaud E, Denizot Y, Aldigier J, Bridoux F, et al.
Kidney Int
. 2000 Sep;
58(3):966-71.
PMID: 10972660
Background: IgA nephropathy is the most common glomerular disease. Mechanisms leading to its occurrence and controlling the evolution of the disease remain largely unknown. Various genetic factors have been found,...